The hypoglycemic activity of tolbutamide and related compounds is well established; however, their mode of action is still debated. Several theories have been postulated (1-5). One of the most widely held is that tolbutamide stimulates the beta cells of the pancreas and the resulting insulin secretion produces the fall in blood sugar (1). The reported ineffectiveness of tolbutamide in depancreatized animals (1) and humans (6) is taken as strong evidence for this theory. With few exceptions these studies were done sometime after recovery from the pancreatectomies. One of us (M.K.) in the past studied the possible pancreatropic effect of another substance, i.e., anterior pituitary growth hormone (7). It was observed that growth hormone had a hypoglycemic effect in acutely depancreatized dogs but not in dogs several days after pancreatectomy. Accordingly, it was thought worthwhile to study the effect of tolbutamide in acutely depancreatized dogs.
The hypoglycemic activity of tolbutamide and related compounds is well established; however, their mode of action is still debated. Several theories have been postulated (1) (2) (3) (4) (5) . One of the most widely held is that tolbutamide stimulates the beta cells of the pancreas and the resulting insulin secretion produces the fall in blood sugar (1) . The reported ineffectiveness of tolbutamide in depancreatized animals (1) and humans (6) is taken as strong evidence for this theory. With few exceptions these studies were done sometime after recovery from the pancreatectomies. One of us (M.K.) in the past studied the possible pancreatropic effect of another substance, i.e., anterior pituitary growth hormone (7) . It was observed that growth hormone had a hypoglycemic effect in acutely depancreatized dogs but not in dogs several days after pancreatectomy. Accordingly, it was thought worthwhile to study the effect of tolbutamide in acutely depancreatized dogs.
METHODS
Adult male and female mongrel dogs were used. The animals were in the postabsorptive state. All the experiments were performed under sodium pentobarbital anesthesia. To assure complete removal of the pancreas the duodenum and pancreas were removed "en bloc." In the dog, the pancreas can be divided into three parts: a middle portion and two limbs. The middle portion is intimately adherent to that portion of the duodenum equivalent to the second, third and fourth parts of the human duodenum. The two "limbs," one to the right and the other to the left of the duodenum, are completely enveloped in omentum, well defined and easily mobilized. Since it is very difficult to remove completely and with certainty that part of the pancreas adherent to the duodenum and related structures, i.e., bile duct, cystic artery, and so fourth, we resected the duodenum and attached pancreas as a whole. The bowel * This investigation was supported by a grant from the American Heart Association. was cut at least one to two inches beyond the junction of duodenum and pancreas (through pyloric end of stomach and through jejunum). Since these were acute experiments no attempt was made to re-establish continuity of bowel. Once having mobilized and resected the duodenum and attached pancreas, the rest of the operation was relatively simple. Since both "limbs" of pancreatic tissue are free in omentum (except at one point, noted below) we could easily make our line of resection at least one-half inch away from, and parallel to the border of, the pancreas. The exception mentioned above is that the distal one-half to one inch of the left wing is closely applied to branches of the splenic artery and vein. At that point two or three tiny arteries and veins communicate between the vessels and pancreatic parenchyma. When these are ligated, the omentum containing the pancreas is easily stripped off the vessels. When the tip of the limb is mobilized the line of resection can be continued. In essence, then, the pancreas is removed intact and certainly completely. Early in the operative series, we did postmortem examinations. However, the difference between pancreas and omental fat is obvious enough at the time of operation to make postmortem examination unnecessary.
Blood samples were collected after administration of the anesthesia, immediately after removal of the pancreas and approximately every 30 minutes thereafter for four to seven hours. The blood glucose was determined by the Nelson-Somogyi method (8) . Almost all of the blood specimens were taken from peripheral veins. On several occasions cardiac punctures were done, without deleterious effects. The sodium tolbutamide (2), 200 mg. per Kg., was dissolved in 15 to 20 ml. of normal saline and rapidly injected intravenously at the times noted.
RESULTS
Two unoperated dogs were given tolbutamide and the results paralleled those reported by others (9) . In both cases the blood sugars fell approximately 60 per cent and the maximum effect was noted within two to four hours after injection.
Five dogs were subjected to pancreatectomy but did not receive tolbutamide (Table I and delayed declines of the blood sugar in depancreatized dogs have been noted previously (7) . After approximately three hours, the blood sugar values started to rise again in those dogs in which a fall had occurred. At the end of the experiments, three and one-half to four hours after pancreatectomy, the blood sugars ranged from 206 to 360 mg. per cent. The "control" blood sugars obtained in several dogs were higher than are usually found in fasting dogs. Increased adrenalin output in frightened, untrained animals is the most likely explanation. The marked hyperglycemia recorded within minutes of removal of the pancreas (zero time) in three dogs (ip, 4p and 2p-T) is also probably explained by excessive adrenalin secretion. It should be noted that the height of the blood sugar following pancreatectomy could not account for the difference in results between the untreated and treated dogs. Dog 2p-T had the highest zero time blood sugar, 350 mg. per cent, immediately after pancreatectomy and yet responded to the tolbutamide with a fall in blood sugar. Dog 1 p-T which had a preinjection level of 194 mg. per cent also responded to the tolbutamide.
Seven dogs were given tolbutamide within two to 10 minutes after removal of the pancreas (Table  I and Figure 1) . Examination of the data reveals that during the first two hours the blood sugars did not rise as would normally be expected after pancreatectomy. Two to four hours after administration of the tolbutamide, the blood sugars started to fall. One dog (7p-T) was followed for seven hours and the hypoglycemic effect was found to persist throughout the period of observation. Figure 1 illustrates the difference between the treated and untreated depancreatized dogs. The blank bars represent the range of blood sugar values, at the times noted, for the untreated group. The cross-hatched bars depict similar values for the tolbutamide treated group. The average values for each set of readings are also noted. It is apparent that there is a striking difference in blood sugar values between the two groups. In every treated dog the last observed blood sugar, four to seven hours after pancreatectomy, was less than the preoperative (control) value. Final blood sugars ranged from 43 to 130 mg. per cent, a marked contrast to those seen in the untreated depancreatized dogs.
The administration of tolbutamide was delayed in four dogs. One, 8p-T, received the drug one hour after pancreatectomy and the others received it two hours after removal of the pancreas (Table  II) . Dog 8p-T showed a response in that five hours after pancreatectomy the blood sugar was only 17 mg. per cent higher than the preoperative value. The blood sugar curves of Dogs 9p-T and 10p-T do not seem to differ significantly from the depancreatized dogs not receiving tolbutamide. However, Dog 1lp-T which, like Dogs 9p-T and 10p-T, received the drug two hours after pancreatectomy, showed a response similar to the dogs receiving the tolbutamide promptly after the pancreas was removed.
It is apparent that when tolbutamide is administered promptly after removal of the pancreas, a distinct hypoglycemic effect results. The blood sugars not only do not rise to the levels seen in untreated depancreatized dogs, but significant decreases in blood sugar occur. The decreases are comparable to those obtained in intact dogs receiving tolbutamide.
Fritz, Morton, Weinstein and Levine (10) have reported somewhat similar studies on three dogs and concluded that no effect occurred when the sulfonylureas (carbutamide) were administered to the acutely depancreatized dog. In our series of 11 dogs, those dogs exhibiting the most consistent effect were given the tolbutamide within 10 minutes of pancreatectomy. Fritz states that "carbutamide was administered 20 to 60 minutes after pancreatectomy." They state that no change was noted in the course of the blood sugar in the three hours that the dogs were followed. All of our dogs but one were followed for four hours or more. It is important to note that the effect became obvious in five of the seven dogs only at the fourth hour or later. One dog received tolbutamide 75 minutes after pancreatectomy and did not clearly show any effect at the end of three hours but did by the fifth hour.
Obviously, the hypoglycemic effect noted in our dogs was not mediated through the pancreas. However, these experiments do not clarify the relationship of insulin to tolbutamide activity. It is likely that the depancreatized dogs were not free of endogenous insulin and insulin may be a requirement for tolbutamide activity. The experiments in which the administration of tolbutamide was delayed were done to test this hypothesis. Turnover studies with labeled insulin (11) indicate that most if not all of the endogenous insulin would have disappeared within the two hours after pancreatectomy. The variable results obtained in the four dogs (two showing hypoglycemic effect and two no change) that received the delayed tolbutamide would then be explained by a lack of an adequate amount of recently secreted insulin. This is consistent with the concept that tolbutamide hypoglycemia requires the presence of some insulin.
However, even if tolbutamide hypoglycemia will not occur in the absence of insulin ( 1), it need not mean that there is a direct relationship or interactivity between them. The two could effect the utilization of glucose at completely different points in the metabolic cycle, but those steps controlled by insulin might have to be intact for tolbutamide to produce hypoglycemia.
These experiments do not exclude the possibility that, in the intact animal, tolbutamide does in addition act by stimulating the pancreas. However, the data presented here do not require that such an explanation be invoked.
SUM MARY
Tolbutamide effects a significant lowering of blood sugar when administered to acutely depancreatized dogs. In these experiments the hypoglycemic action therefore cannot be attributed to a pancreatropic effect. These studies are consistent with the thesis that insulin must be present for tolbutamide to act.
